FRITS VAN RHEE, MD
Osteopathic Medicine at Markham St, Little Rock, AR
License number
Arkansas E-2781
Category
Osteopathic Medicine
Type
Hematology & Oncology
Address
Address
4301 W Markham St #783, Little Rock, AR 72205
Phone
(501) 686-8000
Organization information
See more information about FRITS VAN RHEE at bizstanding.comFrits Van Rhee MD,PHD
4301 W Markham St, Little Rock, AR 72205
Industry:
Internist, Transplant Surgery
Phone:
(501) 686-8000 (Phone)
Frits V. Van Rhee
Frits Van Rhee MD
324 Jack Stephens Dr #8, Little Rock, AR 72205
Categories:
Internal Medicine Physicians & Surgeons
Phone:
(501) 686-8230 (Phone)
Professional information
Dr. Frits Rhee, Greenville SC - MD (Doctor of Medicine)
Specialties:
Hematology
Address:
Upstate Oncology Associates
317 Saint Francis Dr SUITE 340, Greenville 29601
(864) 546-3699 (Phone)
4301 W Markham St SUITE 783, Little Rock 72205
(501) 686-8000 (Phone)
317 Saint Francis Dr SUITE 340, Greenville 29601
(864) 546-3699 (Phone)
4301 W Markham St SUITE 783, Little Rock 72205
(501) 686-8000 (Phone)
Languages:
English
Hospitals:
Upstate Oncology Associates
317 Saint Francis Dr SUITE 340, Greenville 29601
4301 W Markham St SUITE 783, Little Rock 72205
Bon Secours St. Francis Health System
1 Saint Francis Dr, Greenville 29601
Uams Medical Center
4301 West Markham St, Little Rock 72205
317 Saint Francis Dr SUITE 340, Greenville 29601
4301 W Markham St SUITE 783, Little Rock 72205
Bon Secours St. Francis Health System
1 Saint Francis Dr, Greenville 29601
Uams Medical Center
4301 West Markham St, Little Rock 72205
Education:
Medical School
Erasmus Universiteit, Faculteit Der Geneeskunde
Graduated: 1985
Erasmus Universiteit, Faculteit Der Geneeskunde
Graduated: 1985
Frits Van Rhee, Little Rock AR
Specialties:
General Practice, Internal Medicine, Hematology & Oncology, Hematology, Medical Oncology, Transplant Surgery, Hematology
Work:
University of Arkansas
4301 W Markham St, Little Rock, AR 72205 Childrens University Medical Group
1 Childrens Way, Little Rock, AR 72202
4301 W Markham St, Little Rock, AR 72205 Childrens University Medical Group
1 Childrens Way, Little Rock, AR 72202
Education:
Erasmus Universiteit (1985)
Md Phd At Uams
Position:
MD PhD at UAMS
Location:
Little Rock, Arkansas Area
Industry:
Hospital & Health Care
Work:
UAMS
-
MD PhD
Use Of Autologous Effector Cells And Antibodies For Treatment Of Multiple Myeloma
US Patent:
2013005, Mar 7, 2013
Filed:
Oct 30, 2009
Appl. No.:
13/505005
Inventors:
Frits Van Rhee - Little Rock AR, US
International Classification:
A61K 39/395, A61P 35/00
US Classification:
4241331, 4241731, 4241781, 4241581
Abstract:
The present disclosure provides methods for treating multiple myeloma using a combination of autologous expanded and activated NK cells from the patient and an antibody that targets an antigen on myeloma cells and/or an antibody that targets the KIR antigen on NK cells, wherein the antibodies elicit ADCC toward myeloma cells. The present disclosure provides methods for treating multiple myeloma using a combination of autologous NK cells and the anti-CS1 antibody elotuzumab.
Use Of Allogeneic Effector Cells And Anti-Cs1 Antibodies For Selective Killing Of Multiple Myeloma Cells
US Patent:
2008009, Apr 24, 2008
Filed:
Aug 7, 2007
Appl. No.:
11/835260
Inventors:
Daniel AFAR - Fremont CA, US
Frits VAN RHEE - Little Rock AR, US
Frits VAN RHEE - Little Rock AR, US
Assignee:
PDL BIOPHARMA, INC. - Fremont CA
UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCE - Little Rock AR
UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCE - Little Rock AR
International Classification:
A61K 39/395, A61K 31/19, A61K 31/56, A61P 43/00, A61K 31/675, A61K 35/00
US Classification:
424133100, 424093710, 514171000, 514570000, 514081000
Abstract:
Methods for treating MM using anti-CS1 antibodies are provided herein.
Use Of Autologous Effector Cells For Treatment Of Multiple Myeloma
US Patent:
2013005, Feb 28, 2013
Filed:
Oct 30, 2009
Appl. No.:
13/505050
Inventors:
Frits Van Rhee - Little Rock AR, US
Assignee:
University of Arkansas for Medical Science - Little Rock AR
International Classification:
A61K 35/14, A61K 38/20, A61M 5/00, A61P 35/00
US Classification:
424 852, 424 9371, 604522
Abstract:
The present disclosure provides methods for treating multiple myeloma using autologous expanded and activated NK cells.